Erythropoiesis
Investigators at Moffitt Cancer Center release new data on erythropoiesis
Published in Blood Weekly, May 20th, 2010
Current study results from the report, 'Lenalidomide in myelodysplastic syndromes: an erythropoiesis-stimulating agent or more,' have been published. According to recent research from the United States, "Anemia remains the most challenging clinical manifestation to treat in patients with lower-risk myelodysplastic syndromes (MDS). Erythropoiesis-stimulating agents are widely used to treat anemia in such patients, but less than one third respond to these agents, and the duration of response is often limited."
"Lenalidomide, a second-generation immunomodulatory drug (IMiD), is approved by the US Food and Drug Administration for treatment of transfusion-dependent anemia in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-05-20)
More Articles from Blood Weekly
- Blood Research
Findings in blood research reported from M. Malavolta and co-researchers - Clinical Transplantation
Studies from University of Heidelberg yield new information about clinical transplantation - Drug Development
New research on drug development from INSERM summarized - Blood Research
Study findings from Pohang University of Science & Technology broaden understanding of blood research - Thrombosis
Reports summarize thrombosis study results from University Hospital - Blood Transfusion
Researchers from Government Medical College, Department of Medicine report recent findings in blood transfusion - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
